Table 1 The renin-angiotensin-aldosterone system: a new look at an old system published in Hypertension Research in 2022

From: The renin-angiotensin-aldosterone system: a new look at an old system

Basic research

Protection against Ang II-induced cardiac hypertrophy by circ_0018553 [8]

Exaggerated development of Ang II-induced hypertension by IL-23R deficiency [9]

Clinical research

Efficacy of MR antagonists in the treatment of DKD [10]

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension [11]

Safety of a selective inhibitor of aldosterone synthase, Baxdrostat [12]

  1. Ang II angiotensin II, IL23R interleukin 23 receptor, MR mineralocorticoid receptor, DKD diabetic kidney disease